Surgical safety and quality of radical cystectomy and pelvic lymph node dissection after neoadjuvant Durvalumab and Cisplatin/Gemcitabine for muscle invasive bladder cancer: Results from the SAKK 06/17 phase II study

Saved in:
Bibliographic Details
Published inEuropean urology Vol. 83; pp. S230 - S231
Main Authors Afferi, L., Spahn, M., Hayoz, S., Strebel, R.T., Rothschild, S.I., Seifert, H., Özdemir, B.C., Kiss, B., Maletzki, P., Engeler, D., Wirth, G., Hadaschik, B., Lucca, I., John, H., Sauer, A., Müntener, M., Schneider, M., Musilova, J., Petrausch, U., Cathomas, R.
Format Journal Article
LanguageEnglish
Published 01.02.2023
Online AccessGet full text

Cover

More Information
ISSN:0302-2838
DOI:10.1016/S0302-2838(23)00214-2